ELLIOTT JOHN RAYMOND Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$1.11M
Insider Sells Quantity
16
Insider Sells Sum
$36.31M

Insider Activity of ELLIOTT JOHN RAYMOND

Biography of ELLIOTT JOHN RAYMOND

No biography is available at this moment.

2009-08-11PurchaseBoston Scientific Corporation
BSX
director
100,000
0.0066%
$11.06$1.11M-27.88%
2007-02-12SaleZimmer Biomet Holdings, Inc.
ZBH
Chairman, Pres. & CEO
106,825
0.0168%
$30.19$3.23M-1.34%
2007-02-09SaleZimmer Biomet Holdings, Inc.
ZBH
Chairman, Pres. & CEO
106,825
0.0167%
$30.19$3.23M-1.69%
2007-02-08SaleZimmer Biomet Holdings, Inc.
ZBH
Chairman, Pres. & CEO
71,250
0.031%
$85.28$6.08M-3.19%
2007-02-07SaleZimmer Biomet Holdings, Inc.
ZBH
Chairman, Pres. & CEO
75,718
0.0327%
$84.55$6.4M-3.12%
2005-02-16SaleZimmer Biomet Holdings, Inc.
ZBH
Chairman, Pres. & CEO
50,583
0.0068%
$27.30$1.38M-9.06%
2005-02-15SaleZimmer Biomet Holdings, Inc.
ZBH
Chairman, Pres. & CEO
1,166
0.0005%
$82.65$96,370-7.66%
2005-02-14SaleZimmer Biomet Holdings, Inc.
ZBH
Chairman, Pres. & CEO
50,583
0.0069%
$27.30$1.38M-8.11%
2005-02-11SaleZimmer Biomet Holdings, Inc.
ZBH
Chairman, Pres. & CEO
6,751
0.0009%
$27.30$184,302-9.66%
2005-02-10SaleZimmer Biomet Holdings, Inc.
ZBH
Chairman, Pres. & CEO
641
0.0003%
$84.20$53,972-9.77%
2005-02-09SaleZimmer Biomet Holdings, Inc.
ZBH
Chairman, Pres. & CEO
50,583
0.0082%
$32.51$1.64M-8.57%
2005-02-08SaleZimmer Biomet Holdings, Inc.
ZBH
Chairman, Pres. & CEO
50,583
0.0081%
$32.51$1.64M-9.38%
2004-02-20SaleZimmer Biomet Holdings, Inc.
ZBH
Chairman, Pres. & CEO
54,000
0.0229%
$77.70$4.2M+2.37%
2004-02-19SaleZimmer Biomet Holdings, Inc.
ZBH
Chairman, Pres. & CEO
54,000
0.0228%
$77.70$4.2M+1.74%
2004-02-18SaleZimmer Biomet Holdings, Inc.
ZBH
Chairman, Pres. & CEO
14,770
0.0018%
$22.02$325,235+2.06%
2004-02-17SaleZimmer Biomet Holdings, Inc.
ZBH
Chairman, Pres. & CEO
22,356
0.0094%
$77.00$1.72M+2.48%
2004-02-13SaleZimmer Biomet Holdings, Inc.
ZBH
Chairman, Pres. & CEO
25,452
0.0031%
$22.04$560,962+2.39%
Total: 17
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.